TransMedics Group, Inc. TMDX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.29% | 100.71% | -93.06% | 333.34% | -30.33% |
| Total Depreciation and Amortization | 4.20% | -15.42% | 60.22% | 8.05% | 1.86% |
| Total Amortization of Deferred Charges | 25.00% | 14.29% | 40.00% | 25.00% | 0.00% |
| Total Other Non-Cash Items | 35.40% | 6.71% | 122.89% | -796.94% | 7.03% |
| Change in Net Operating Assets | 36.93% | -124.10% | -112.62% | -119.12% | -30.49% |
| Cash from Operations | 108.01% | -29.45% | -28.92% | -50.39% | -24.05% |
| Capital Expenditure | -18.44% | 80.65% | -136.28% | -103.49% | 15.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -93.32% | 80.65% | -136.28% | -103.49% | 15.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 219.62% | -74.13% | 25.85% | -17.99% | -46.69% |
| Repurchase of Common Stock | -258.97% | 71.74% | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -297.42% | -74.22% | 21.39% | -14.89% | -48.64% |
| Foreign Exchange rate Adjustments | 63.35% | 23.24% | -447.87% | 944.44% | -98.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.51% | 225.86% | -139.15% | -66.17% | -27.46% |